PRMW.TO
Primo Brands Corporation
TorontoCADEQUITY
DELAYED
Last price
37.40
▲ 2.04 (5.77%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
35.36
Day high
37.43
Day low
35.91
Volume
310.48K
Market cap
$6.00B
P/E (TTM)
52.68
52W range
19.04 – 38.76
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PRMW.TO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
4.71M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | FOSS ERIC J. Chief Executive Officer |
BUY | 84.00K | $2.00M | Direct |
| Aug 7, 26 | LEE TONY W Director and Beneficial Owner of more than 10% of a Class of Security |
SELL | 20.41M | $497.40M | Indirect |
| Aug 7, 26 | ORCP III DE TOPCO GP, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
SELL | 20.41M | $497.40M | Indirect |
| Jul 14, 26 | PRIYADARSHI SUDHANSHU SHEKHAR Director |
STOCK | 5.71K | $0 | Direct |
| Jun 30, 26 | STANBROOK STEVEN P Director |
STOCK | 1.23K | $29.99K | Direct |
| May 15, 26 | BRIMMER ANDREA C Director |
STOCK | 7.20K | $0 | Direct |
| Apr 28, 26 | CATES SUSAN ELIZABETH Director |
STOCK | 8.89K | $0 | Direct |
| Apr 28, 26 | FOWDEN JEREMY STEPHEN GARY Director |
STOCK | 8.89K | $0 | Direct |
| Apr 28, 26 | BOMHARD BRITTA B Director |
STOCK | 8.89K | $0 | Direct |
| Apr 28, 26 | PAK MINSOK Director |
STOCK | 8.89K | $0 | Direct |
| Apr 28, 26 | METROPOULOS C DEAN Director |
STOCK | 429 | $8.45K | Direct |
| Apr 28, 26 | STANBROOK STEVEN P Director |
STOCK | 8.89K | $0 | Direct |
| Apr 28, 26 | CRAMER MICHAEL JOHN Director |
STOCK | 8.89K | $0 | Direct |
| Apr 28, 26 | PRIM BILLY DEAN Director |
STOCK | 8.89K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AUSHER JASON R |
Officer | 106.71K | Stock Award(Grant) |
FOSS ERIC J. |
Chief Executive Officer | 573.81K | Purchase |
FOWDEN JEREMY STEPHEN GARY |
Director | 1.30M | Stock Award(Grant) |
HASS DAVID W |
Chief Financial Officer | 449.49K | Stock Award(Grant) |
LEE TONY W |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Sale |
ORCP III DE TOPCO GP, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
POE MARNI MORGAN |
General Counsel | 545.63K | Conversion of Exercise of derivative security |
PRIM BILLY DEAN |
Director | 1.09M | Stock Award(Grant) |
RIETBROEK ROBBERT |
Chief Executive Officer | 586.35K | Purchase |
STANBROOK STEVEN P |
Director | 195.50K | Stock Award(Grant) |
Fundamentals
Market cap$6.00B
Enterprise value$18.88B
Revenue (TTM)$6.74B
Gross profit$2.07B
EBITDA$1.34B
Net income$111.70M
EPS (TTM)$0.71
Free cash flow$403.34M
Total cash$368.90M
Total debt$5.70B
Book value / share$11.33
Shares outstanding160.40M
Float262.20M
Short % of float—
Dividend yield—
Beta (5Y)0.72
Valuation & profitability ratios
Trailing P/E52.68
Forward P/E23.52
PEG ratio—
Price / sales—
Price / book3.30
EV / revenue2.80
EV / EBITDA14.08
Gross margin30.75%
Operating margin11.50%
Profit margin1.49%
Return on equity3.59%
Return on assets4.16%
Debt / equity191.17
Current ratio1.05
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.82B | +3.1% |
| Next quarter | — | — | $1.60B | +3.2% |
| Current year | — | — | $6.84B | +2.6% |
| Next year | — | — | $7.08B | +3.5% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.30%
Held by institutions105.89%
Institutions holding491
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
0.72
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 7, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 21, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 16, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 11, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 4, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Apr 14, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Mar 30, 26 | Deutsche Bank | MAINTAINED | Hold | Hold |
| Mar 27, 26 | Jefferies | UPGRADE | Hold | Buy |
| Mar 5, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Mar 2, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Feb 27, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
Headlines
Dow Jones Futures: Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 9m ago
Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?
Insider Monkey · 10m ago
The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.
Motley Fool · 14m ago
Prediction: Oklo Won't Book Its First Commercial Power Revenue Before 2028
Motley Fool · 18m ago
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 21m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 27m ago
FIA Hails Success of Landmark INDYCAR Freedom 250 Grand Prix as Motorsport Takes Centre Stage in Washington D.C.
Business Wire · 31m ago
The next big oil trade may have nothing to do with oil stocks
TheStreet · 31m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.